To study the role of levosimendan on cardiovascular determinants of contractility and afterload in patients with AHF following STEMI treated with percutaneous coronary intervention (PCI)
Latest Information Update: 07 Apr 2020
At a glance
- Drugs Levosimendan (Primary)
- Indications Acute heart failure
- Focus Therapeutic Use
Most Recent Events
- 07 Apr 2020 New trial record